What is the study?
Verily is partnering with Duke University and Stanford Medicine to conduct a longitudinal observational study that will follow approximately 10,000 participants for five years. The Baseline Study is designed to develop a well-defined reference, or “baseline,” of health and a rich data platform that may be used to better understand the transition from health to disease.
How are you making it happen?
This longitudinal study will characterize participants across clinical, molecular, imaging, sensor, self-reported, behavioral, psychological, environmental and other health-related measurements from onsite visits, continuous data collection through sensor technology, and regular engagement via an online portal and mobile app. When integrated, the data are expected to provide a range of expected values among a diverse population, and provide biomarkers of disease-related transitions, including those related to cardiovascular disease and cancer.